Illumina HiSeq drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (8)
Papers in which this entity is mentioned.
- Integrative reconstruction of cancer genome karyotypes using InfoGenomeR. (2021)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
- Pan-cancer analysis of whole genomes. (2020)
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
- Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. (2016)
- Transcriptome sequencing of a large human family identifies the impact of rare noncoding variants. (2014)
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. (2013)
- Characterizing and measuring bias in sequence data. (2013)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| illumina hiseq | drug | 11 | 17 |